US50127T1097
US50127T1097
Kura Oncology, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 67.482.000 | 53.883.000 | 25.2% |
| Cost of Revenue | 57.000 | -- | -- |
| Gross Profit | 67.425.000 | 53.883.000 | 25.1% |
| 371.056.000 | 247.078.000 | 50.2% | |
| Operating Income | -303.631.000 | -193.195.000 | 57.2% |
| Pretax Income | -278.369.000 | -171.965.000 | 61.9% |
| Net Income Common Stockholders | -278.666.000 | -173.983.000 | 60.2% |
| -- | -- | -- | |
| -- | -- | -- |